Cargando…

Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”

Detalles Bibliográficos
Autores principales:	Nagasaka, Misako, Azmi, Asfar S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183396/ https://www.ncbi.nlm.nih.gov/pubmed/37197620 http://dx.doi.org/10.21037/tlcr-23-71

Ejemplares similares

Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022)

Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019)

KRAS G12C mutation: from undruggable target to potentially agnostic biomarker
por: El Osta, Badi
Publicado: (2023)

KRAS mutation: from undruggable to druggable in cancer
por: Huang, Lamei, et al.
Publicado: (2021)

Commentary: PROTACs make undruggable targets druggable: Challenge and opportunity
por: Lu, Bin, et al.
Publicado: (2021)

Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
por: Lam, Kuen Kuen, et al.
Publicado: (2023)

Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
por: Hantschel, Oliver, et al.
Publicado: (2011)

CodeBreak 200: Sotorasib Has Not Broken the KRAS(G12C) Enigma Code
por: Zhang, Shannon S, et al.
Publicado: (2023)

Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021)

Drugging the “undruggable” DNA-binding domain of STAT3
por: Zhang, Jian-Ting, et al.
Publicado: (2016)

Covalent inhibitor targets KRas(G12C): A new paradigm for drugging the undruggable and challenges ahead
por: Li, Hui-yu, et al.
Publicado: (2021)

Targeting STATs for cancer therapy: “Undruggable” no more
por: Frank, David A.
Publicado: (2012)

Drugging the Undruggable: Advances on RAS Targeting in Cancer
por: Molina-Arcas, Miriam, et al.
Publicado: (2021)

Central nervous system tumors: Spotlight on India
por: Munshi, Anusheel
Publicado: (2016)

Seeking sanctuary: rethinking asylum and mental health
por: Jannesari, Sohail, et al.
Publicado: (2020)

The Future of Medicinal Chemistry, PROTAC, and Undruggable Drug Targets
por: Poso, Antti
Publicado: (2021)

Targeting the “undruggable” RAS - new strategies - new hope?
por: Mörchen, Britta, et al.
Publicado: (2019)

Sanctuary /
por: Faulkner, William, 1897-1962
Publicado: (1980)

Sanctuary
por: Kellerman, Faye
Publicado: (1994)

Primary Angiitis of the Central Nervous System: A Great Mimicker
por: Modi, Tanish, et al.
Publicado: (2022)

Central Nervous System (CNS) and Systemic Autoimmune Disease: Coexistence or More?
por: Vibha, Deepti, et al.
Publicado: (2022)

Indictment by Association: Once Is Not Enough
por: Pellett, Philip E.
Publicado: (2015)

Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets
por: Kharkar, Prashant S.
Publicado: (2014)

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib
por: Brazel, Danielle, et al.
Publicado: (2022)

KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
por: Bannoura, Sahar F., et al.
Publicado: (2022)

Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system
por: Hida, Toyoaki
Publicado: (2023)

Central nervous system and Cryptococcus neoformans
por: Gaona-Flores, Veronica A.
Publicado: (2013)

Drugging the undruggables: exploring the ubiquitin system for drug development
por: Huang, Xiaodong, et al.
Publicado: (2016)

Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets
por: Moon, Seonghyeon, et al.
Publicado: (2018)

Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
Publicado: (2021)

The choroid plexus stroma constitutes a sanctuary for paediatric B‐cell precursor acute lymphoblastic leukaemia in the central nervous system
por: Fernández‐Sevilla, Lidia M, et al.
Publicado: (2020)

Mechanotransduction mechanisms in central nervous system glia
por: Cullimore, Brenan, et al.
Publicado: (2022)

Sickle cell trait: not as benign as once thought
por: Khan, Uqba, et al.
Publicado: (2014)

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes
por: Trkulja, Carolina L., et al.
Publicado: (2021)

Targeting undruggable carbohydrate recognition sites through focused fragment library design
por: Shanina, Elena, et al.
Publicado: (2022)

MicroRNA-708 emerges as a potential candidate to target undruggable NRAS
por: Pang, Jia Meng, et al.
Publicado: (2023)

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
por: Xie, Xin, et al.
Publicado: (2023)

Challenges in diagnosis of isolated central nervous system vasculitis
por: Amara, Amy W, et al.
Publicado: (2011)

Distinct metabolic preference of atypical KRAS mutant
por: Cheong, Heesun
Publicado: (2020)

Food for Thought
por: Pal, Ranabir, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nea7pcv9alos4ob204b0diutml